Octave Specialty Group heads into its May 7 earnings release with the most bullish options tilt of the past year — a striking setup for a stock that has shed nearly 9% over the last month.
The clearest signal comes from the options market. The put/call ratio has collapsed to 0.20, almost two and a half standard deviations below its 20-day average of 0.28, making it the lowest defensive reading of the past 52 weeks. Call demand is dramatically outpacing puts — investors are leaning hard on upside into the print. That divergence from the recent trend stands out against a backdrop of steady price weakness: OSG closed at $4.22 on Wednesday, down 3.7% on the day and nearly 5% on the week. Bulls in the options market and sellers in the equity market are currently pulling in opposite directions.
Short positioning does not explain much of the tension. SI accounts for roughly 3% of the free float — modest by any standard, and declining. It fell more than 21% over the past month, as shorts trimmed consistently through April after a brief spike near 3.4% in early April. The borrow market is equally relaxed: cost to borrow has more than halved over the past week to just 0.51%, and availability is ample. There is no squeeze dynamic at work here, and no meaningful short-side pressure building ahead of the release.
The fundamental setup gives the options bulls something concrete to anchor on. Estimates point to normalised net income of around $12.9 million on revenues of approximately $331 million. More strikingly, OSG ranks in the 98th percentile on EPS surprise history — the company has a strong track record of beating expectations. The one prior earnings print in the dataset offers a data point: after February 2026 results, the stock rose 8.4% in a single day and extended that to a 10% gain over the following five days. That reaction likely explains much of the call accumulation into today's event.
Institutional ownership is stable. BlackRock holds just under 10% of shares, Vanguard roughly 5.6%. The CEO, Claude LeBlanc, bought 12,000 shares at $7.59 in January — a price well above where the stock trades now — and received a further award in March. The insider picture is not alarming, but it does underline how far the stock has drifted from prices at which management was actively adding exposure. With the P/E at roughly 10x and the book value multiple at a deep 0.26x, the valuation case for bulls is straightforward: the stock is cheap relative to earnings power if the numbers hold. The earnings print will test whether the company's strong beat history extends to Q1 — and whether that alone is enough to reverse two months of price erosion.
See the live data behind this article on ORTEX.
Open OSG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
